As the field of regenerative medicine continues to advance, the incorporation of AI is playing a transformative role in the ...

Novo Nordisk and AI-driven protein design company Gensaic are to develop tissue-targeted therapies for cardiometabolic ...

The EC has authorised the marketing of Bavarian Nordic's Vimkunya chikungunya vaccine for individuals as young as 12 years ...

Regenerative medicine, a rapidly advancing field, can be generally defined as a therapeutic methodology for the repair, ...

AbbVie is entering the obesity treatment market with a $2.3bn licensing agreement to acquire rights to a long-acting amylin ...

BridgeBio Oncology has entered into a merger agreement with Helix Acquisition Corp II to form a combined entity.

Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly for molecular glue therapeutics.

As Rare Disease Day is commemorated on 28 February, experts discuss the barriers to gene therapy access for some rare ...

Teesside University's National Horizons Centre (NHC) is committed to turning groundbreaking ideas into practical solutions.

The CHMP has recommended the approval of AbbVie's upadacitinib (Rinvoq) for treating adults with giant cell arteritis (GCA).

With issues in therapy delivery and a barren trial landscape, short-term chances for a commercial galactosemia treatment are ...

A survey has shown that pharma companies have low confidence their rare disease medicines can launch in the UK.